Now Screening & Treating Patients at Our Sydney CBD Clinic
Are you looking for a new option to help with persistent low moods?
GoodMind Therapeutics is now accepting patients for intranasal therapy in Sydney CBD, as well as the greater Sydney area and the Central Coast of New South Wales.
Intranasal Therapy provides a fast-acting, medically supervised option for those who haven’t found relief with conventional mental health treatments.
Our Sydney CBD clinic is in a central, convenient location, making it easily accessible by public transport, even if you live in Greater Sydney or beyond.
Here, you’ll be supported by a team of experienced and caring professionals who are dedicated to providing safe, structured, and evidence-based care.
A New Innovative Option for Veteran Mental Health
Veterans often face complex mental health challenges, and traditional treatments don’t always provide the relief they need.
Intranasal therapy is designed to work quickly, offering a pathway for those who have tried other approaches without success.
What makes intranasal therapy different?
✔️ Fast-acting relief – Unlike some conventional options, this therapy is designed to take effect quickly.
✔️ Clinically supported – Every session is supervised by medical professionals in a controlled setting.
✔️ A caring, multidisciplinary approach – We integrate medical expertise with psychological support to help you through the process.
Fully Funded by DVA (Subject to Approval)
If you hold a DVA card, you may be eligible for fully funded treatment through the Department of Veterans’ Affairs, subject to DVA approval on a case-by-case basis.
This may include funding for transport to and from the Sydney CBD treatment clinic with no out-of-pocket expenses if eligible.
Our team can help guide you through the process and assess your eligibility.
Is This Therapy Right for You?
This treatment is prescription-only and not suitable for everyone. A doctor will assess whether it’s the right fit based on your medical history and symptoms. To qualify, you must have tried conventional treatments without success.
If you’re a veteran experiencing treatment-resistant low moods, we encourage you to reach out and see if intranasal therapy in Sydney CBD could be an option for you.
Our Sydney CBD clinic is now screening and accepting new patients for intranasal therapy.
We are also screening for the great er Sydney region and the Central Coast of New South Wales with treatment available in the Newcastle area.
Take the next step toward relief with expert-led care in a supportive environment.
Complete our screening form HERE and one of the GoodMind therapeutics team will be in touch.
Have questions, visit this page or reach out to our team during business hours.
GoodMind Therapeutics is now screening for NEW patients in Sydney & the central coast N.S.W.
What is psilocybin?
Psilocybin is a naturally occurring psychedelic produced by over 200 species of mushroom. It has historically been used as a psychedelic agent for religious and spiritual ceremonies, as well as a therapeutic option for neuropsychiatric conditions.
Once ingested psilocybin metabolises to psilocin, and given its structural similarity to serotonin, activates the serotonin 5-HT2A receptor, which mediates many different functions in our minds; like mood, imagination, learning and perception.
It is this receptor activation that is thought to produce psilocybin’s psychedelic effects. These effects, which are dose-dependent, can include heightened perception, thinking in new ways, experiencing intense emotions connected to sensory experiences, distortions of time, and hallucinations of closed-eye and open-eye visuals and auditory sensations.
The psychedelic therapy experience aims to help individuals gain new perspectives on their thoughts and emotions and may help to break negative thought patterns and behaviours.
Open label clinical trial break through goodmind
It's time to break through goodmind
What is MDMA?
MDMA isn’t a classical psychedelic, and has no overt hallucinatory effects, but can mimic psilocybin in producing feelings of depersonalization and altered perception and thought. MDMA is an empathogen drug meaning it can increase feelings of empathy and kindness, social acceptance, and connection to others. MDMA acts by increasing the release of serotonin, dopamine and norepinephrine, although the enhanced release of oxytocin may also be a factor.
MDMA can be used during psychotherapy, with the aim to reduce defensiveness, increasing relaxation and improving mood. This may enable someone to revisit traumatic memories and work through their emotions without being re-traumatised or finding the associated fear too overwhelming.
The research
There is a growing body of research exploring the use of psychedelic therapy for the treatment of mental health conditions, particularly treatment-resistant conditions where conventional treatment has been tried numerous times and fallen short or failed.
Some research studies have demonstrated reductions in symptoms through the implementation of psychedelic-assisted therapy protocols (Griffiths et al., 2016; Mithoefer et al., 2018). Furthermore, long-term follow-up assessments have shown some participants experiencing enduring improvements in mental health and quality of life (Ross et al., 2016; Carhart-Harris et al., 2018). These findings warrant further research into psychedelic therapy as an approach that transcends conventional treatment modalities, paving the way for new options in mental healthcare.
